Development of biomarkers: What are the scientific hurdles?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of biomarkers: What are the scientific hurdles?

Published:2007-12 Issue:9 Volume:5 Page:10-11
ISSN:1359-6349
Container-title:European Journal of Cancer Supplements
language:en
Short-container-title:European Journal of Cancer Supplements

Author:

Håkansson L.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference8 articles.

1. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma;Sheehan;Mol Cell Proteom,2005

2. Proliferation marker Ki-67 in early breast cancer;Urruticoechea;J Clin Oncol,2005

3. Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial

4. Neoadjuvant trastuzumab induces apoptosis in primary breast cancers;Mohsin;J Clin Oncol,2005

5. Effect of interferon-alpha on tumour-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma;Håkansson;J Interferon Cytokine Res,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3